tradingkey.logo
tradingkey.logo
Search

Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline

ReutersSep 22, 2025 11:13 AM
facebooktwitterlinkedin

- Gilead Sciences Inc GILD.O:

  • ENSOMA ANNOUNCES $53 MILLION FINANCING TO SUPPORT KEY CLINICAL MILESTONES FOR EN-374 AND CONTINUED DEVELOPMENT OF IN VIVO HEMATOPOIETIC STEM CELL ENGINEERING PIPELINE

  • ENSOMA : INVESTORS INCLUDE GILEAD WHICH HAS ALSO APPOINTED AN EXECUTIVE TO ENSOMA BOARD OF DIRECTORS AS PART OF ITS INVESTMENT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI